← Back to all trials
Recruiting
NCT07912827
Bioequivalence Study Between YHP2508A and YHR2601 in Healthy Subjects
Conditions: Healthy Subjects (HS)
Sex: All
Ages: 19 Years – 54 Years
Healthy volunteers: Yes
Phase: PHASE1
Enrollment: 44
Sponsor: Yuhan Corporation
Location: H+ Yangji Hospital Seoul
Summary
An open-label, randomized, fasting, single-dose, oral administration, 2-sequence, 4-period, replicate crossover study to evaluate bioequivalence between YHP2508A and YHR2601 in healthy subjects
Eligibility Criteria
Inclusion Criteria:
* BMI 18-30 kg/m2
* Those without clinically significant congenital or chronic diseases
Exclusion Criteria:
* Those who have participated in a bioequivalence study or other clinical trials and have been administered investigational products within 6 months prior to the first administration
* Those who are judged ineligible to participate in the trial by the principal investigator
* Female volunteers who are pregnant, suspected to be pregnant or breathfeeding
Source: ClinicalTrials.gov (NCT07912827). StuddyBuddy aggregates publicly available trial information.
